UNSPSC 51162028: Ephedrine/secobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162028 Ephedrine/secobarbital is a Commodity code, but the recent state and local opportunities tagged under it do not align with its nominal pharmaceutical-ingredient scope. The two most recent solicitations — Seminole County, Florida's IFB for naloxone and drug deactivation systems, and Hall County, Georgia's RFQ/P for on-site pharmacy services — address naloxone dispensing and comprehensive medication management for employee and retiree health plans, not ephedrine or secobarbital specifically. The code shows a mismatch between its catalog definition and what state and local buyers are actually procuring under it, suggesting either a tagging error in the source data or a drift in how the code is being applied in practice by issuing bodies.

Seminole County, Florida released IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's community health building; the deadline was July 26, 2023. Hall County, Georgia issued RFQ/P #47-010 on May 4, 2026, for an on-site pharmacy services provider to serve approximately 3,005 individuals in the county's group health plans; responses were due June 4, 2026, for a contract beginning January 1, 2027, with technical qualifications weighted at 80 percent and cost at 20 percent. Both solicitations require E-Verify compliance and standard insurance coverages. Given the limited volume of recent activity and the apparent code-to-opportunity mismatch, the code warrants verification against the actual pharmaceutical products or services your firm supplies before pursuing opportunities tagged here.